Kevin Adamzek
Impact in
-
- Radiopharmaceutical Chemistry and Applications
- Monoclonal and Polyclonal Antibodies Research
- Medical Imaging Techniques and Applications
-
- HER2/EGFR in Cancer Research
- Peptidase Inhibition and Analysis
Papers in
-
- Muscle Physiology and Disorders 3
- Glycosylation and Glycoproteins Research 1
- Oncology 5
- HER2/EGFR in Cancer Research 5
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Guus A.M.S. van Dongen (6 shared papers)Alex J. Poot (3 shared papers)Daniëlle J. Vugts (2 shared papers)Gerard W.M. Visser (1 shared paper)Thomas L. Mindt (1 shared paper)Gilles Gasser (1 shared paper)Ibai E. Valverde (1 shared paper)Cristina Mari (1 shared paper)
- Journals
- European Journal of Nuclear Medicine and Molecular Imaging (2 papers)Genes Brain & Behavior (1 paper)Expert Opinion on Drug Delivery (1 paper)Journal of Nuclear Medicine (1 paper)Oncotarget (1 paper)
- Partner nations
- NetherlandsSwitzerlandGermany
In The Last Decade
Kevin Adamzek
10 papers receiving 320 citations
Peers
Comparison fields: 5 of 48
- Radiology, Nuclear Medicine and Imaging 198
- Oncology 103
- Aging 5
- Molecular Biology 125
- Pulmonary and Respiratory Medicine 39
Countries citing papers authored by Kevin Adamzek
This map shows the geographic impact of Kevin Adamzek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin Adamzek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin Adamzek more than expected).
Fields of papers citing papers by Kevin Adamzek
This network shows the impact of papers produced by Kevin Adamzek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin Adamzek. The network helps show where Kevin Adamzek may publish in the future.
Co-authors
The 25 scholars most cited alongside Kevin Adamzek, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 116 | |
| 2 | 2021 | 59 | |
| 3 | 2020 | 47 | |
| 4 | 2016 | 35 | |
| 5 | 2018 | 22 | |
| 6 | 2019 | 17 | |
| 7 | 2024 | 10 | |
| 8 | 2024 | 7 | |
| 9 | 2017 | 6 | |
| 10 | 2019 | 3 |
About Kevin Adamzek
Kevin Adamzek is a scholar working on Molecular Biology, Oncology, Radiology, Nuclear Medicine and Imaging, Genetics and Rehabilitation, having authored 10 papers that have together received 322 indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (5 papers), Monoclonal and Polyclonal Antibodies Research (4 papers), Radiopharmaceutical Chemistry and Applications (4 papers), Muscle Physiology and Disorders (3 papers), Colorectal Cancer Treatments and Studies (1 paper), Muscle metabolism and nutrition (1 paper), Muscle activation and electromyography studies (1 paper) and Glycosylation and Glycoproteins Research (1 paper). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (198 citations), Oncology (103 citations), Aging (5 citations), Molecular Biology (125 citations) and Pulmonary and Respiratory Medicine (39 citations). Kevin Adamzek has collaborated with scholars based in Netherlands, Switzerland and Germany. Frequent co-authors include Guus A.M.S. van Dongen, Alex J. Poot, Daniëlle J. Vugts, Gerard W.M. Visser, Thomas L. Mindt, Gilles Gasser, Ibai E. Valverde, Cristina Mari, Sabrina Oliveira and Paul M.P. van Bergen en Henegouwen. Their work appears in journals such as European Journal of Nuclear Medicine and Molecular Imaging, Genes Brain & Behavior, Expert Opinion on Drug Delivery, Journal of Nuclear Medicine and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.